Drug-eluting Stents More Effective, Equally As Safe As Bare Metal Stents, Clinical Trial Suggests
Wednesday, October 15, 2008 - 12:36
in Health & Medicine
Late-breaking data from the HORIZONS AMI (Harmonizing Outcomes with RevascularIZatiON and Stents in Acute Myocardial Infarction) trial reveal that after one year, use of a drug-eluting (paclitaxel) stent demonstrated significantly reduced rates of target lesion revascularization and binary angiographic restenosis when compared to the use of a bare metal stent in heart attack patients.
Read the whole article on Science Daily
More from Science Daily
Related
- Drug-eluting stents more effective, equally as safe as bare metal stents in clinical trialWed, 15 Oct 2008, 12:22:35 EDT
- Drug-eluting stents prove more effective, equally as safe as bare-metal stentsWed, 6 May 2009, 17:42:54 EDT
- Drug-eluting stents better than bare-metal stents for heart attack patientsFri, 25 Sep 2009, 15:35:45 EDT
- Analysis of drug-eluting stents data demonstrates safety, efficacy in on-and-off-label useTue, 16 Jun 2009, 12:45:06 EDT
- Best use of drug-eluting stentsTue, 2 Sep 2008, 9:28:42 EDT